Lobe Sciences (TSE:LOBE) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Lobe Sciences Ltd., a North American Biopharmaceutical Company, announced the results of its 2024 Annual General Meeting, where Fred Sancilio, Harry Jacobson, and Wesley Ramjeet were appointed to its board. Shareholders voted on key resolutions, including the re-appointment of the company’s auditor, Davidson LLP. The company is known for its focus on rare diseases and the development of psilocin-based compounds for neurological therapies.
For further insights into TSE:LOBE stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue